C. Harley

发表

A comparison of comorbidity measurements to predict healthcare expenditures.

J. Farley, Joel F Farley, C. Harley, 2006, The American journal of managed care.

Influence of medication choice and comorbid diabetes: the cost of bipolar disorder in a privately insured US population

G. L’italien, W. Carson, C. Harley, 2007, Social Psychiatry and Psychiatric Epidemiology.

Health care costs for patients with cancer at the end of life.

J. Kallich, L. Newcomer, C. Paoli, 2012, Journal of oncology practice.

The comparative effectiveness of rosuvastatin vs. other statins in patients with an increased risk of failure to reach NCEP ATP III goal

H. Heien, C. Harley, S. Gandhi, 2008, International journal of clinical practice.

Cholesterol Management in a Population of Managed Care Enrollees

C. Harley, Setareh A. Williams, K. Mcdonough, 2003 .

Prevalence and cost of HIV-associated weight loss in a managed care population

C. Harley, A. Phillips, T. Darkow, 2009, Current medical research and opinion.

Impact of universal varicella vaccination on the use and cost of antibiotics and antivirals for varicella management in the United States

C. Harley, J. Fergie, M. Pawaskar, 2022, PloS one.

Costs Associated with Management of Cervical Human Papillomavirus-Related Conditions

Jennifer S. Smith, C. Harley, D. Kruzikas, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Drug administration frequency and provider office visit patterns for oncology patients during treatment with erythropoietic agents: an analysis of four observational studies.

T. Mark, C. Pashos, C. Harley, 2006, Clinical therapeutics.

Cost of fractures commonly associated with osteoporosis in a managed-care population

E. Badamgarav, C. Harley, D. Macarios, 2010, Journal of medical economics.

Treatment compliance and dosage administration among rheumatoid arthritis patients receiving infliximab, etanercept, or methotrexate.

J. Frytak, C. Harley, N. Tandon, 2003, The American journal of managed care.

Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care

H. Heien, C. Harley, S. Gandhi, 2008, Expert opinion on pharmacotherapy.

Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.

H. Heien, C. Harley, S. Gandhi, 2007, The American journal of geriatric pharmacotherapy.

Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population

P. Hodgkins, Paul Hodgkins, C. Harley, 2010, Current medical research and opinion.

Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population

P. Hodgkins, C. Harley, Fang Liu, 2011, Current medical research and opinion.

Original research Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population

P. Hodgkins, C. Harley, L. Christensen, 2011 .

Socioeconomic Status and Health over the Life Course

M. Finch, J. Frytak, C. Harley, 2003 .

Burden of illness among patients at high risk versus low risk for major cardiovascular events

C. Harley, H. Shah, S. Sander, 2010, Journal of medical economics.

Costs and outcomes of noncardioembolic ischemic stroke in a managed care population

N. Engel-Nitz, C. Harley, H. Shah, 2010, Vascular health and risk management.

Additional Stroke-Related and Non–Stroke-Related Cardiovascular Costs and Hospitalizations in Managed-Care Patients After Ischemic Stroke

P. Gorelick, C. Harley, C. Roberts, 2009, Stroke.

Recognition & management of varicella infections and accuracy of antimicrobial recommendations: Case vignettes study in the US

Taylor T Schwartz, C. Harley, J. Fergie, 2022, PloS one.

A comparison of mortality and costs associated with FOLFOX versus FOLFIRI in stage IV colorectal cancer

B. Seal, C. Harley, S. Shetty, 2011, Journal of medical economics.

Anticoagulation therapy in patients with chronic atrial fibrillation: a retrospective claims data analysis*

C. Harley, A. Riedel, M. Nelson, 2005, Current medical research and opinion.

Adherence to a Fixed-Dose Combination of Rosiglitazone/Glimepiride in Subjects Switching from Monotherapy or Dual Therapy with a Thiazolidinedione and/or a Sulfonylurea

B. Arondekar, C. Harley, T. Darkow, 2010, The Annals of pharmacotherapy.

Increased risk of serious comorbidities in a cohort of AD patients compared to a similar non-AD cohort

D. Malone, T. Mclaughlin, C. Harley, 2009, Alzheimer's & Dementia.

A Comparison of Comorbidity Measurements to Control for Confounding in Health Outcomes Studies

J. Farley, C. Harley, Joshua W. Devine, 2005 .

Prevalence of Parkinson's disease-induced psychosis in a large U.S. managed care population.

R. Holt, C. Harley, G. Goldberg, 2010, The Journal of neuropsychiatry and clinical neurosciences.

The prevalence of cardiorenal risk factors in patients prescribed nonsteroidal anti-inflammatory drugs: data from managed care.

C. Harley, S. Wagner, 2003, Clinical therapeutics.

Understanding practice patterns and low-density lipoprotein cholesterol goal attainment implications of switching patients from simvastatin in a health plan setting.

J. Mckenney, M. Bullano, C. Harley, 2007, The American journal of managed care.

Understanding the evolution of coverage policies for prophylaxis treatments of hemophilia A without inhibitors: a payer Delphi panel

K. Batt, M. Graf, C. Harley, 2021, Journal of managed care & specialty pharmacy.